Skip to content

Stepping Into Lifestyle Changes

Community-Based Strategies to Reduce Cardiometabolic Disease in the Deep South

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05625321
Acronym
SILC
Enrollment
273
Registered
2022-11-22
Start date
2023-03-27
Completion date
2026-06-30
Last updated
2025-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure, Overweight and Obesity, Pre-Diabetes

Brief summary

The purpose of this study is to promote healthy weight loss among African American women, age 30 or older, who are pre-diabetic and/or have high blood pressure and who live, work, or worship in select rural communities throughout Alabama and Mississippi. The goal of the study is to help reduce the burden of obesity, diabetes, and high blood pressure for these women and to collect information on the reach, effectiveness, adoption, implementation, maintenance, and cost effectiveness of our two evidence-base weight loss programs.

Detailed description

This study leverages two evidence-based interventions (EBIs) that have been culturally-adapted for the target population and have previously achieved clinically-relevant weight loss and other clinical outcomes (educational group weight loss intervention) along with improvements in diet and physical activity (home gardening intervention). Combining these EBIs addresses multiple domains (behavioral, personal environment, sociocultural) and levels (individual, interpersonal, community) of influence on risk factors for obesity and other cardiometabolic diseases prevalent in the Deep South. These interventions, delivered by local lay staff and non-academic partners, have a high potential for sustainability; however, there is a need to further evaluate the external validity and implementation-related barriers and facilitators to maximize reach, adoption and implementation. The investigators will employ a pragmatic, multilevel, cluster-randomized, type 1 hybrid effectiveness-implementation trial. A total of 264 Black women (age ≥ 30 years) with overweight or obesity and pre-diabetic or hypertensive from 12 rural counties (6 Alabama, 6 Mississippi) will receive either the combined educational group weight loss intervention plus a home gardening intervention or the educational group weight loss classes alone. The specific aims are to compare interventions on: (1) primary outcomes related to implementation effectiveness (reach, adoption, maintenance of health behaviors), (2) secondary outcomes on clinical effectiveness, and (3) cost effectiveness. Findings will inform discussions with coalition partners to achieve our long-term goal of widely disseminating and sustaining multi-level interventions to reduce the multiple chronic disease burden and health disparities in the Deep South.

Interventions

BEHAVIORALEducational Group Weight Loss Classes

Participants will be provided with educational materials on weight loss, and have opportunities to increase their exercise and make changes to their diet.

BEHAVIORALHome Gardening Intervention

Participants will receive tools to establish their own home garden, increasing their access to fresh fruits and vegetables.

Sponsors

University of Mississippi Medical Center
CollaboratorOTHER
National Institute on Minority Health and Health Disparities (NIMHD)
CollaboratorNIH
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
30 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* self-identifies as Black and/or African American * ≥ 30 years old * a measured BMI \>25 kg/m2 and at least one other cardiometabolic risk factor (physician diagnosis of pre-diabetes and/or hypertension within past 2 years) * lives, works, or worships in one of the 12 intervention communities and expresses no intentions to move outside of that community in the 18 months following enrollment * a willingness to participate in the study for the 18-months duration.

Exclusion criteria

* being or planning to become pregnant during the 18-month study duration * a baseline blood pressure and/or glucose that is outside of the normal range and a medical provider does not provide clearance to participate * medical contraindications

Design outcomes

Primary

MeasureTime frameDescription
Weight0, 6, and 12 monthsChanges in Weight, measured in pounds
BMI0, 6, and 12 monthsChanges in BMI, calculated as a person's weight in kilograms divided by the square of height in meters
Waist Circumference0, 6, and 12 monthsChanges in waist circumference, measured in centimeters
Dietary Intake0, 6, and 12 monthsChanges in diet, measured using a questionnaire

Secondary

MeasureTime frameDescription
Diastolic and Systolic Blood Pressure0, 6, and 12 monthsChanges in values over time, using a calibrated automatic sphygmomanometer and following NHLBI protocols
Perceived Quality of Life0, 6, and 12 monthsChanges in Quality of Life as measured by the EuroQol-5 Dimension survey (EQ-5D-5L). Condition states range from 1-5 with 1 meaning the participant has no problems or symptoms and 5 meaning they have are unable to perform the activity or are extremely impacted by the condition. Self reported health is measured on a 1 to 100 scale with 1 being the worst possible health and 100 being the best possible health.
Fasting Glucose0, 6, and 12 monthsChanges in glucose readings, collected by finger-stick
Cholesterol Levels0, 6, and 12 monthsChanges in LDL and HDL values/ratio, collected by finger-stick
Physical Activity0, 6, and 12 monthsChanges in physical activity, measured by the International Physical Activity Questionnaire (IPAQ). For the IPAQ survey, participants will be asked to indicate if they have completed low (sitting or walking) levels of activity, moderate levels of activity, and/or high levels of activity in the last 7 days.They will also be asked to provide the number of days they do each activity and the time, in minutes, they spend doing the activity.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026